Drew R. Jones, Ph.D.
Affiliations: | 2011 | Biochemistry and Molecular Biology | University of Arkansas for Medical Sciences, United States |
Area:
Biochemistry, PharmacologyGoogle:
"Drew Jones"Parents
Sign in to add mentorGrover P. Miller | grad student | 2011 | UAMS | |
(Elucidating warfarin metabolic pathways and developing novel analytical methods paves the way for improving clinical care.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Curran DM, Grote A, Nursimulu N, et al. (2020) Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets. Elife. 9 |
Wang X, Cho JH, Poudel S, et al. (2020) JUMPm: A Tool for Large-Scale Identification of Metabolites in Untargeted Metabolomics. Metabolites. 10 |
Parker SJ, Amendola CR, Hollinshead KER, et al. (2020) Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer. Cancer Discovery |
Curran DM, Grote A, Nursimulu N, et al. (2019) Author response: Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets Elife |
Xie B, Wang Y, Jones DR, et al. (2018) Isotope Labeling-assisted Evaluation of Hydrophilic and Hydrophobic Liquid Chromatograph-Mass Spectrometry for Metabolomics Profiling. Analytical Chemistry |
Wang X, Jones DR, Shaw TI, et al. (2018) Target-decoy Based False Discovery Rate Estimation for Large-scale Metabolite Identification. Journal of Proteome Research |
Kim SY, Jones DR, Kang JY, et al. (2018) Regioselectivity Significantly Impacts Microsomal Glucuronidation Efficiency of R/S-6, 7-, and 8-Hydroxywarfarin. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-25 |
Jones DR, Wu Z, Chauhan D, et al. (2014) A nano ultra-performance liquid chromatography-high resolution mass spectrometry approach for global metabolomic profiling and case study on drug-resistant multiple myeloma. Analytical Chemistry. 86: 3667-75 |
Jones DR, Boysen G, Miller GP. (2013) Erratum to “Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma” [J. Chromatogr. B 879 (2011) 1056–1062] Journal of Chromatography B. 919: 61 |
Kim SY, Kang JY, Hartman JH, et al. (2012) Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins. Drug Metabolism Letters. 6: 157-64 |